MTOR anticorps (AA 1766-2144)
Aperçu rapide pour MTOR anticorps (AA 1766-2144) (ABIN2585005)
Antigène
Voir toutes MTOR (mTOR) AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
Clone
-
-
Épitope
- AA 1766-2144
-
Specificité
- Human MTOR
-
Purification
- Immunoaffinity purified
-
Immunogène
-
Human recombinant protein fragment corresponding to amino acids 1766-2144 of human MTOR(NP_004949) produced in E. coli.
Type of Immunogen: Recombinant protein -
Isotype
- IgG2a
-
-
-
-
Indications d'application
- Approved: WB (1:2000)
-
Commentaires
-
Target Species of Antibody: Human
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- Lot specific
-
Buffer
- PBS, pH 7.3, 1 % BSA, 50 % glycerol, 0.02 % sodium azide
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Conseil sur la manipulation
- Minimize freezing and thawing.
-
Stock
- -20 °C
-
Stockage commentaire
- Store at -20°C. Avoid freeze-thaw cycles.
-
-
- MTOR (mTOR) (Mechanistic Target of Rapamycin (serine/threonine Kinase) (mTOR))
-
Autre désignation
- MTOR
-
Sujet
-
Name/Gene ID: MTOR
Subfamily: PI3/PI4
Family: Protein Kinase
Synonyms: MTOR, FRAP1, FRAP2, FRAP, Mammalian target of rapamycin, RAFT1, Rapamycin and FKBP12 target 1, RAPT1, Rapamycin target protein 1 -
ID gène
- 2475
-
NCBI Accession
- NP_004949
-
Pathways
- Signalisation PI3K-Akt, Signalisation RTK, AMPK Signaling, Interferon-gamma Pathway, Fc-epsilon Receptor Signaling Pathway, EGFR Signaling Pathway, Neurotrophin Signaling Pathway, Regulation of Actin Filament Polymerization, Regulation of Muscle Cell Differentiation, Regulation of Cell Size, Skeletal Muscle Fiber Development, Regulation of Carbohydrate Metabolic Process, Autophagy, CXCR4-mediated Signaling Events, BCR Signaling, L'effet Warburg
Antigène
-